SDLPharmaceuticals
Southern Palladium Ltd — Cash Flow Statement
₹34.93
+0.00%
Southern Palladium Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 1.86 Cr | 2.12 Cr | 1.80 Cr | 7.03 Cr | — |
| End Cash Position | 0.59 Cr | 0.93 Cr | 0.40 Cr | 0.19 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -2000.00 | — | 1000.00 | — | — |
| Beginning Cash Position | 0.93 Cr | 0.40 Cr | 0.19 Cr | 0.71 Cr | — |
| Changes In Cash | -0.34 Cr | 0.53 Cr | 0.20 Cr | -0.52 Cr | — |
| Financing Cash Flow | -1.15 Cr | -2.09 Cr | -2.30 Cr | -5.50 Cr | — |
| Net Other Financing Charges | 2000.00 | — | -1.30 Cr | -0.02 Cr | 1000.00 |
| Interest Paid Cff | -0.60 Cr | -0.72 Cr | -1.00 Cr | -1.08 Cr | — |
| Net Issuance Payments Of Debt | -0.55 Cr | -1.37 Cr | -1.30 Cr | -4.39 Cr | — |
| Net Long Term Debt Issuance | -0.55 Cr | -1.37 Cr | -1.30 Cr | -4.39 Cr | — |
| Investing Cash Flow | -1.05 Cr | 0.12 Cr | 0.53 Cr | -2.05 Cr | — |
| Net Other Investing Changes | 0.49 Cr | 0.48 Cr | 0.43 Cr | 0.25 Cr | — |
| Interest Received Cfi | 0.04 Cr | 0.06 Cr | 0.11 Cr | 0.10 Cr | — |
| Net Investment Purchase And Sale | -1.62 Cr | -0.04 Cr | 0.13 Cr | -3.49 Cr | — |
| Net PPE Purchase And Sale | 0.05 Cr | -0.38 Cr | -0.14 Cr | 1.09 Cr | — |
| Sale Of PPE | 0.05 Cr | — | 0.04 Cr | 1.09 Cr | 2.00 Cr |
| Purchase Of PPE | 0.00 | -0.38 Cr | -0.17 Cr | 0.26 Cr | — |
| Operating Cash Flow | 1.86 Cr | 2.50 Cr | 1.98 Cr | 7.03 Cr | — |
| Taxes Refund Paid | 0.66 Cr | -0.04 Cr | -0.05 Cr | -0.18 Cr | — |
| Change In Working Capital | 1.51 Cr | 0.27 Cr | 0.39 Cr | 5.94 Cr | — |
| Change In Other Current Liabilities | -0.07 Cr | -0.64 Cr | -0.72 Cr | -1.53 Cr | — |
| Change In Other Current Assets | 0.57 Cr | 0.06 Cr | 0.38 Cr | -0.86 Cr | — |
| Change In Payable | 0.71 Cr | 0.08 Cr | 0.55 Cr | 0.83 Cr | — |
| Change In Inventory | 0.18 Cr | 0.42 Cr | 0.38 Cr | -1.14 Cr | — |
| Change In Receivables | 0.06 Cr | 0.34 Cr | -0.32 Cr | -0.09 Cr | — |
| Other Non Cash Items | 0.19 Cr | 0.28 Cr | 0.91 Cr | 0.82 Cr | — |
| Depreciation And Amortization | 1.09 Cr | 1.64 Cr | 2.17 Cr | 2.17 Cr | — |
| Depreciation | 1.09 Cr | 1.64 Cr | 2.15 Cr | 2.13 Cr | — |
| Gain Loss On Investment Securities | -0.01 Cr | -0.70 Cr | -37000.00 | -0.28 Cr | — |
| Gain Loss On Sale Of PPE | -0.43 Cr | 0.14 Cr | -0.02 Cr | -0.26 Cr | — |
| Net Income From Continuing Operations | -1.08 Cr | 0.80 Cr | -5.52 Cr | -10.37 Cr | — |
| Capital Expenditure | — | -0.38 Cr | -0.17 Cr | — | — |
| Amortization Cash Flow | — | 77000.00 | 0.02 Cr | 0.04 Cr | — |
| Purchase Of Investment | — | — | -0.17 Cr | — | — |
| Issuance Of Debt | — | — | — | -4.39 Cr | — |
| Cash Dividends Paid | — | — | — | -0.02 Cr | — |
| Long Term Debt Issuance | — | — | — | -4.39 Cr | — |
| Provisionand Write Offof Assets | — | — | — | — | 0.20 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Southern Palladium Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.